{
    "nctId": "NCT03502395",
    "briefTitle": "Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion",
    "officialTitle": "Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion and Its Relation to Post-mastectomy Pain: a Prospective Double Blinded Study",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer, Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Serum Opiorphin level",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged between 18 and 60 years old with breast cancer and underwent mastectomy, American society of Anesthesiologist I or II\n\nExclusion Criteria:\n\n* Patients with contralateral breast cancer, metastatic tumor, morbid obesity (BMI\\> 40), allergy to an amide local anesthetic, or morphine sulphate, heart block, renal, or liver dysfunction, or substance abuse disorder, or chronic opioid use",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}